Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Kazumasa, Kamei"'
Autor:
Shigeki Nakamura, Masashi Mikami, Tomoyuki Hayamizu, Naohiro Yonemoto, Camille Moyon, Mark Gouldson, Catriona Crossan, Jeffrey Vietri, Kazumasa Kamei
Publikováno v:
Expert Review of Vaccines, Vol 23, Iss 1, Pp 546-560 (2024)
Background The 23-valent pneumococcal polysaccharide vaccine (PPSV23) is used in the Japanese National Immunization Program for older adults and adults with increased risk for pneumococcal disease, however, disease incidence and associated burden rem
Externí odkaz:
https://doaj.org/article/5239dd86e93040829e02bc8ac2bf6317
Autor:
Masayoshi Shinjoh, Kanae Togo, Tomoyuki Hayamizu, Naohiro Yonemoto, Junko Morii, Johnna Perdrizet, Kazumasa Kamei
Publikováno v:
Expert Review of Vaccines, Vol 23, Iss 1, Pp 485-497 (2024)
Background The Japanese National Immunization Program currently includes the pediatric 13 valent pneumococcal conjugate vaccine (PCV13) to prevent pneumococcal infections. We aimed to evaluate the cost-effectiveness of 20-valent PCV (PCV20) as a pedi
Externí odkaz:
https://doaj.org/article/71b05513c01b4d099126da3986cf1959
Autor:
Mitsuhiro Nagano, Kazumasa Kamei, Hiroyuki Matsuda, Chihiro Takahashi, Jingyan Yang, Koji Wada, Naohiro Yonemoto
Publikováno v:
Expert Review of Vaccines, Vol 23, Iss 1, Pp 349-361 (2024)
Background The aim of this study was to evaluate the public health and economic impact of the COVID-19 booster vaccination with BNT162b2 in Japan during an Omicron-dominant period from early 2022.Research design and methods A combined cohort Markov d
Externí odkaz:
https://doaj.org/article/652a717f6bf04d74aa9b71e9676d10dc
Autor:
Takao Takeshima, Akira Yuasa, Yukie Michelle Lloyd, Louis Patrick Watanabe, Kazumasa Kamei, Akiho Terasawa, Josh Coulter, Lucy Abraham, Brett Hauber, Masahiro Iijima
Publikováno v:
Neurology and Therapy, Vol 13, Iss 6, Pp 1661-1683 (2024)
Abstract Introduction Migraine is a debilitating headache disorder with a high prevalence in Japan that imposes significant societal burden. Although the Japanese Clinical Practice Guideline for Headache Disorders 2021 recommends both acute and preve
Externí odkaz:
https://doaj.org/article/d2b54b5efad244bc9436e01c0807bcc5
Publikováno v:
Infectious Diseases and Therapy, Vol 13, Iss 10, Pp 2155-2177 (2024)
Abstract Introduction Japan will be transitioning from the free-of-charge COVID-19 vaccination program to annual periodic vaccination under a national immunization program for old adults and high-risk patients from 2024 fall/winter season. The policy
Externí odkaz:
https://doaj.org/article/8bed62a875af4e43bab0846949c3e920
Autor:
Naruhiko Ishiwada, Rina Akaishi, Yasuhiro Kobayashi, Kanae Togo, Naohiro Yonemoto, Moe Matsuo, Shinnosuke Kaneko, Amy W. Law, Kazumasa Kamei
Publikováno v:
Infectious Diseases and Therapy, Vol 13, Iss 7, Pp 1665-1682 (2024)
Abstract Introduction Respiratory syncytial virus (RSV) is one of the major causes of respiratory tract infections among children. Until recently, the monoclonal antibody palivizumab was the only RSV prophylaxis available in Japan. In 2024, the bival
Externí odkaz:
https://doaj.org/article/e4484d8b1a2844a6a518eae7db045f8b
Autor:
Kouki Nakamura, Kazumasa Kamei, Jenny Austin, Simran Marwaha, James Piercy, Peter Anderson, Masayo Sakaki-Yumoto, Manabu Ohyama
Publikováno v:
Dermatology and Therapy, Vol 14, Iss 1, Pp 151-167 (2023)
Abstract Introduction Alopecia areata (AA) is characterized by non-scarring scalp and/or body hair loss and can negatively impact patient mental health. Data are limited on the alignment of patient and physician perceptions of AA severity with each o
Externí odkaz:
https://doaj.org/article/1b0f240ec55e4c8c8d3d3f7d8464c238
Autor:
Kazumasa Kamei, Hidehisa Saeki, Takanori Tsuchiya, Tomohiro Hirose, Eduardo Campos‐Alberto, Fumihiro Matsumoto, Noritoshi Yoshii, Shinichi Imafuku
Publikováno v:
Journal of Cutaneous Immunology and Allergy, Vol 4, Iss 5, Pp 109-119 (2021)
Abstract Objectives This study was conducted to assess changes in the real‐world treatment of atopic dermatitis (AD) in Japan. Methods Patients from the JMDC Claims Database with ≥1 confirmed diagnosis of AD, an identifiable medical care start da
Externí odkaz:
https://doaj.org/article/53e494470fe44ec3b6417c0b5c1889cb
Autor:
Akira Yuasa, Naohiro Yonemoto, Kazumasa Kamei, Toshiaki Murofushi, Michael LoPresti, Ankush Taneja, Jake Horgan, Shunya Ikeda
Publikováno v:
Advances in Therapy. 39:5327-5350
In light of the lack of an agreed international standard for how to conduct cost-effectiveness analyses (CEAs), including cost-utility analyses (CUAs) from a societal perspective, there is uncertainty regarding to what extent the inclusion of product
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d0830497ae1743ae7a0070a6a757784
https://doi.org/10.1007/s12325-022-02321-z
https://doi.org/10.1007/s12325-022-02321-z
Autor:
Manabu Ohyama, Peter Anderson, James Piercy, Simran Marwaha, Jenny Austin, Kouki Nakamura, Kazumasa Kamei, Masayo Sakaki-Yumoto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5e7c24c8a375fbf7262b953bc63f7871
https://doi.org/10.26226/m.641999e460d56100127c27c4
https://doi.org/10.26226/m.641999e460d56100127c27c4
